The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.585
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.585
High: 0.00
Low: 0.00
Prev. Close: 0.585
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Provexis says partnership will widen use of Fruitflow

Fri, 18th Nov 2016 10:42

(ShareCast News) - Developer of the Fruitflow heart-health functional food product, Provexis, announced on Friday that the company's alliance partner for Fruitflow, DSM Nutritional Products, has entered into a strategic collaboration agreement for Fruitflow with BY-HEALTH Co, a substantial listed Chinese dietary supplement business.The AIM-traded firm said the strategic collaboration agreement between DSM and BY-HEALTH will focus on the development of new products that contribute to cardiovascular health, to include the establishment of relevant evaluation and testing procedures to accord with Chinese technical and regulatory standards.It said the development process will target the creation of new products for people who are at risk of cardiovascular disease, particularly to include those over 40 years of age."There are already more than 230m people in China who are thought to have cardiovascular disease, and a significant increase in cardiovascular events is expected in China over the course of the next decade based on population aging and growth alone," its board said in a statement."The company believes that Fruitflow has the potential to play an import role in primary prevention in the Chinese market."Provexis said the collaboration agreement was signed at the Guangzhou International Symposium on Nutrition and Health, which had the theme 'Nutrition and Chronic Diseases: New Development, New Challenges'.The company's lead scientist Dr Niamh O'Kennedy, who played a key role in the development of Fruitflow, gave a presentation to the Guangzhou International Symposium concerning the cardiovascular benefits of Fruitflow.Provexis said it will provide scientific and technical support for Fruitflow to DSM and BY-HEALTH throughout the collaboration.
More News
27 Sep 2018 13:33

Provexis Annual Loss Widens, Starts New Year On Positive Note

LONDON (Alliance News) - Provexis PLC reported Thursday that a big rise in share-based payments led to a slightly widened loss for the 2018 financial year.However, Provexis said it has made

Read more
4 Jul 2018 11:32

Provexis Appoints Frederic Boned As Non-Executive Director

LONDON (Alliance News) - Provexis PLC said Wednesday it appointed Frederic Boned as non-executive director with immediate effect.Currently, Boned is EMEA vice president of DSM's Human a

Read more
30 Dec 2016 07:53

Provexis Narrows Loss But Will Need To Raise Funds In Next 4 Months (ALLISS)

Read more
30 Dec 2016 07:18

Provexis boosts revenue and narrows loss

(ShareCast News) - Developer of the proprietary Fruitflow heart-health functional food ingredient Provexis posted its unaudited interim results for the six months to 30 September on Friday, with total revenue for the period of £0.12m. The AIM-traded company said that was a threefold increase from th

Read more
20 Dec 2016 09:04

Provexis reports positive results from Fruitflow tests

(ShareCast News) - Developer of the Fruitflow heart-health functional food ingredient Provexis updated the market on its collaboration agreement with the University of Oslo on Tuesday, undertaking further research into the relationship between Fruitflow and blood pressure regulation. The AIM-traded

Read more
23 Sep 2016 15:05

UK Shareholder Meetings Calendar - Next 7 Days

Read more
29 Jun 2016 14:59

Provexis chairman joins possible fundraising

(ShareCast News) - Provexis, the developer and licenser of the proprietary Fruitflow heart health food ingredient, updated the market on its ongoing seeking of funding on Wednesday, with an uplift in interest thanks to its chairman. The AIM-traded firm had announced on 9 June that it was in late sta

Read more
29 Jun 2016 09:49

WINNERS & LOSERS SUMMARY: Investors Hammer Brammer For Profit Warning

Read more
29 Jun 2016 08:45

Provexis Launches New Product, Continues Fundraising Talks (ALLISS)

Read more
9 Jun 2016 13:38

Provexis In Late Stage Talks With Investors For Fundraising (ALLISS)

Read more
31 May 2016 10:51

Provexis Expects To Report "Another Strong Year Of Progress"

Read more
7 Jan 2016 17:15

DIRECTOR DEALINGS SUMMARY: Provexis Directors Buy 4.9 Million Shares

Read more
7 Jan 2016 15:04

DIRECTOR DEALINGS: Provexis Directors Buy 4.9 Million Shares

Read more
22 Dec 2015 11:22

Provexis Remains Positive On Outlook As Pretax Loss Widens Slightly

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.